Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomics in Nursing Curricula: A Qualitative Study of Portuguese Educators' Views.

International nursing review·2026
Same author

Auditory P300 Potentials as State Biomarkers for Mild-to-Moderate Depression in Spinocerebellar Ataxia Type 2.

Cerebellum (London, England)·2026
Same author

The ATXN2 9 bp duplication in SCA3: clarifying evidence and correcting misinterpretations.

Acta neuropathologica communications·2026
Same author

Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulation.

Journal of neuroimmunology·2026
Same author

Monitoring the Progression of Pre-Ataxic Gait in SCA2 with Inertial Sensors Over Four Years.

Cerebellum (London, England)·2026
Same author

Validation of the SODA in Spinocerebellar Ataxia Type 2.

Cerebellum (London, England)·2026
Same journal

Genetic services in Pakistan: a review highlighting limitations and opportunities for improvement.

Journal of community genetics·2026
Same journal

Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025.

Journal of community genetics·2026
Same journal

Impact of revised severity criteria on the acceptability of PGT-M for childhood-onset cancer predisposition syndromes: a survey of genetic professionals in Japan.

Journal of community genetics·2026
Same journal

Oncogenetics training in Brazilian medical genetics residency programs: current landscape and challenges.

Journal of community genetics·2026
Same journal

A primary care pharmacogenetic precision medicine pilot based on specific Māori tribal ethical frameworks and principles.

Journal of community genetics·2026
Same journal

Underutilisation of hydroxyurea in sickle cell disease: a global scoping review of multilevel barriers and facilitators.

Journal of community genetics·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.6K

SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.

Tania Cruz-Mariño1, Yaimeé Vázquez-Mojena, Luis Velázquez-Pérez

  • 1Predictive Genetics Department, Center for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba, taniacruz@hotmail.ca.

Journal of Community Genetics
|April 21, 2015
PubMed
Summary
This summary is machine-generated.

Cuba

More Related Videos

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.8K
Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 14, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.6K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.8K
Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

1.3K

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases
  • Clinical Genetics

Background:

  • Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disorder caused by ATXN2 gene CAG repeat expansion.
  • Cuba exhibits the world's highest SCA2 prevalence, necessitating robust predictive testing programs.

Purpose of the Study:

  • To analyze the outcomes and ethical challenges of Cuba's pioneering SCA2 predictive testing program.
  • To inform modifications in genetic testing protocols for late-onset neurodegenerative disorders.

Main Methods:

  • Retrospective analysis of medical records from 1193 individuals undergoing SCA2 predictive testing over 13 years.
  • Evaluation of presymptomatic and prenatal test uptake rates and associated ethical considerations.

Main Results:

  • Presymptomatic and prenatal test uptake rates were 43.4% and 23.9%, respectively.
  • Ethical challenges included protocol length, adolescent participation, and decisions regarding affected fetuses.
  • High frequency of large normal ATXN2 alleles (23-31 repeats) presented unique issues.

Conclusions:

  • The Cuban SCA2 predictive testing program adapted its guidelines to address ethical challenges and improve accessibility.
  • Community-level genetic counseling and health education are crucial for successful predictive testing programs.
  • Lessons learned in Cuba offer valuable insights for international efforts in late-onset neurodegenerative disease genetic testing.